Telmisartan/amlodipine
Combination drug
From Wikipedia, the free encyclopedia
Telmisartan/amlodipine, sold under the brand name Twynsta among others, is a fixed-dose combination medication used to treat high blood pressure.[3] It is a combination of telmisartan, an angiotensin II receptor antagonist; and amlodipine, as the besilate, a calcium channel blocker.[3] It is taken by mouth.[3]
| Combination of | |
|---|---|
| Telmisartan | Angiotensin II receptor antagonist |
| Amlodipine | Calcium channel blocker |
| Clinical data | |
| Trade names | Twynsta, others |
| License data | |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| KEGG | |
Common side effects include dizziness, swelling, and back pain.[3] Severe side effects may include low blood pressure, kidney problems, electrolyte problems, and a heart attack.[3] Use during pregnancy may harm the baby.[3] Telmisartan works by blocking the effects of angiotensin II while amlodipine works by decreasing calcium ion entry into smooth muscle and heart muscle.[3]
The combination was approved for medical use in the United States in 2009.[3] The combination is on the World Health Organization's List of Essential Medicines.[5] It is available as a generic medication.[6]
